Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Efficacy and safety of fish oil preparation for Crohn's disease

June 21, 1996

Oxis' BXT-51072 will enter phase I

June 21, 1996

5-HT4 agonists developed by Nisshin Flour Milling

June 14, 1996

Carrington Laboratories' Aliminase enters phase III trials

June 14, 1996

Ansan and Boehringer Inglheim enter apafant agreement

June 7, 1996

Single-dose hepatitis A vaccine available

June 7, 1996

Oral toxoid vaccine under development by OraVax

June 7, 1996

Commencement of SYNSORB Cd phase I trial expected

June 7, 1996

Centocor's CenTNF sees positive results

May 31, 1996

Nitto Boseki claims serine protease inhibitors

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...